1	Se	se	P00CN000	-	-	0-2	321(0)_ANS_clinical_caseMIR	SENT1	-	-
2	trata	tratar	VMIP3S0	-	-	3-8	321(0)_ANS_clinical_caseMIR	SENT1	-	-
3	de	de	SPS00	C0332285	atributo	9-11	321(0)_ANS_clinical_caseMIR	SENT1	-	-
4	una	una		C0205447_1	calificador_1	12-15	321(0)_ANS_clinical_caseMIR	SENT1	-	-
5	espondiloartropatia	espondiloartropatia	NCFS000	-	-	16-35	321(0)_ANS_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
6	,	,	Fc	-	-	35-36	321(0)_ANS_clinical_caseMIR	SENT1	-	-
7	iniciaría	iniciar	VMIC3S0	-	-	37-46	321(0)_ANS_clinical_caseMIR	SENT1	-	-
8	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	47-58	321(0)_ANS_clinical_caseMIR	SENT1	-	-
9	con	con	SPS00	C0332287	atributo	59-62	321(0)_ANS_clinical_caseMIR	SENT1	-	-
10	metotrexato	metotrexato	NCMS000	C0025677#C0949359	producto#sustancia	63-74	321(0)_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
11	.	.	Fp	-	-	75-76	321(0)_ANS_clinical_caseMIR	SENT1	-	-

